2014 CMHC - Program Agenda

Wednesday - Thursday - Friday - Saturday

Wednesday, October 22, 2014

11:15am - 12:30pm Symposium (non-CME)
The Effect of a Once-Weekly Therapy on A1C and
Weight Over 3 Years
Sponsored by AstraZeneca Diabetes
Neil I. Kaminsky, MD
12:30pm - 2:00pm Symposium (non-CME)
Advancing Paradigm Changes in Type 2 Diabetes Management
Sponsored by Janssen Pharmaceuticals, Inc.
Robert Busch, MD
2:00pm - 3:15pm Symposium (non-CME)
Addressing Chronic Weight Management with Targeted Pharmacotherapy
Sponsored by Eisai, Inc.
Harold E. Bays, MD
3:15pm - 4:30pm Symposium (non-CME)
Understanding High Triglycerides
Sponsored by AstraZeneca
JoAnne M. Foody, MD
4:30pm - 5:45pm Symposium (non-CME)
SGLT2 Inhibition: A Glucuretic Treatment Option for Your Adult Patients With Type 2 Diabetes
Sponsored by AstraZeneca Diabetes
Neil I. Kaminsky, MD
5:45pm - 7:00pm Symposium (non-CME)
Chronic Weight Management in Adults: A Treatment Option
Sponsored by Takeda Pharmaceuticals America, Inc.
Harold E. Bays, MD
7:00pm - 8:30pm Symposium (non-CME)
New Diagnostic Tools for the Prevention and Comprehensive
Management of Diabetes
Sponsored by Health Diagnostic Laboratory, Inc.
Timothy E. Graham, MD

Thursday, October 23, 2014

6:15am - 7:45am CME Breakfast Symposium A
The Triglycerides Conundrum:
Practical Clinical Guidance for Reducing Residual CV Risk
Supported by an educational grant from Amarin Pharma, Inc.
Harold E. Bays, MD (Chair)
Christie M. Ballantyne, MD
Eliot A. Brinton, MD
6:15am - 7:45am CME Breakfast Symposium B
Confronting Racial and Ethnic Disparities in Cardiometabolic Disease
Sponsored by the American College of Cardiology in collaboration with the National Minority Quality Forum and the Association of Black Cardiologists | Supported in part by educational grants from Arbor Pharmaceuticals and Merck & Co.
Laurence Sperling, MD (Chair)
Keith C. Ferdinand, MD
JoAnne M. Foody, MD
Kris Vijay, MD
SESSION I: DYSLIPIDEMIA, ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE RISK REDUCTION
8:00am - 8:10am Opening Remarks Christie M. Ballantyne, MD
8:10am - 9:40am CVD Prevention Guidelines Update:
Clinical Impact and Current Controversies
moderator:
Christie M. Ballantyne, MD
presenters & discussants:
George L. Bakris, MD
Robert H. Eckel, MD
Jay S. Skyler, MD
Sidney C. Smith, Jr., MD
Neil J. Stone, MD
9:40am - 10:30am Keynote Session
  • Update on Inflammation in the Pathogenesis of Cardiometabolic Disease
  • Testing the Inflammation Hypothesis: The CIRT and CANTOS Trials
moderator:
Christie M. Ballantyne, MD
presenters & discussants:
Peter Libby, MD
Paul M. Ridker, MD
10:30am - 11:30am Morning Break/Exhibit Hall  
11:30am - 12:30pm Late-Breaking Clinical Trials and FDA Update moderator:
Christie M. Ballantyne, MD
presenters & discussants:
Deepak L. Bhatt, MD, MPH
Robert H. Eckel, MD
Keith C. Ferdinand, MD
Jay S. Skyler, MD
12:45pm - 2:15pm CME Lunch Symposium A
Obesity Management 2014:
New Perspectives and Therapeutic Options for a Growing Problem
Supported by an educational grant from Novo Nordisk, Inc.
Robert H. Eckel, MD (Chair)
Jamy D. Ard, MD
George A. Bray, MD
Michael D. Jensen, MD
12:45pm - 2:15pm CME Lunch Symposium B
Closing the Gaps in the Continuum of Care for Patients
with Acute Coronary Syndromes:
Implications for Optimal Antiplatelet Use
Supported by an educational grant from AstraZeneca
Deepak L. Bhatt, MD, MPH (Chair)
Jeffrey L. Anderson, MD
Robert A. Harrington, MD
P. Gabriel Steg, MD
12:45pm - 2:15pm CME Lunch Symposium C
Evolving Strategies for LDL-Lowering: Novel Targets and Treatments for CVD Risk Reduction
Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals
Terry A. Jacobson, MD (Chair)
Eliot A. Brinton, MD
Sekar Kathiresan, MD
Evan A. Stein, MD, PhD
2:30pm - 3:30pm Expert Debates in Antithrombotic Therapy
  • Do diabetic patients with CAD need more than just aspirin?
  • Should patients with stents receive DAPT for more than a year?
  • Should patients with aFib receive novel anticoagulants?
moderator:
Deepak L. Bhatt, MD, MPH
presenters & discussants:
Robert A. Harrington, MD
P. Gabriel Steg, MD
3:30pm - 4:15pm Afternoon Break/Exhibit Hall  
4:15pm - 4:45pm Keynote Session
Implications of Recent Genetic Findings on Management of Cardiovascular Risk
Sekar Kathiresan, MD
4:45pm - 5:45pm Clinical Controversies in Lipid Management:
Case-Based Presentations & Discussion
moderator:
Christie M. Ballantyne, MD
presenters & discussants:
Robert H. Eckel, MD
JoAnne M. Foody, MD
Sekar Kathiresan, MD
Neil J. Stone, MD
5:45pm Closing Remarks Christie M. Ballantyne, MD
5:45pm - 7:00pm Exhibit Hall Welcome Reception  
7:00pm - 9:00pm CME Dinner Symposium A
The Wide Spectrum of Familial Hypercholesterolemia: Discovering Your Highest Risk Patients and Optimizing Treatment
Supported by educational grants from Aegerion Pharmaceuticals, Inc. and Genzyme, A SANOFI COMPANY | Endorsed by The FH Foundation
Seth J. Baum, MD (Chair)
Catherine Davis Ahmed
Sarah de Ferranti, MD, MPH
Patrick M. Moriarty, MD
Pamela B. Morris, MD
Scott Radabaugh
7:00pm - 9:00pm CME Dinner Symposium B
Novel and Emerging Combinations to Achieve Glycemic Control and Reduce Cardiometabolic Risk: A Focus on Incretin-Based Therapy and SGLT2 Inhibitors
Supported by an educational grant from AstraZeneca
George L. Bakris, MD (Chair)
Mark E. Molitch, MD
Sunder Mudaliar, MD
Richard E. Pratley, MD

Friday, October 24, 2014

6:15am - 7:45am CME Breakfast Symposium A
Optimizing Antihypertensive Therapies in High-Risk and Difficult-to-Treat Patients with Hypertension
Supported by an educational grant from Forest Laboratories, Inc.
George L. Bakris, MD (Chair)
Keith C. Ferdinand, MD
Thomas Giles, MD
Michael A. Weber, MD
6:15am - 7:45am CME Breakfast Symposium B
Innovations in GLP-1 Receptor Agonist Therapy: Individualized Treatment Strategies to Overcome Barriers and Reduce Cardiometabolic Risk in Type 2 Diabetes Mellitus
Supported by an educational grant from Lilly USA, LLC
John B. Buse, MD, PhD (Chair)
Samuel Dagogo-Jack, MD
Richard E. Pratley, MD
6:15am - 7:45am CME Breakfast Symposium C
New Targets and Treatments for LDL Lowering:
Role of PCSK9 Inhibitors
Supported by an educational grant from Amgen
Christie M. Ballantyne, MD (Chair)
Michael H. Davidson, MD
Marc S. Sabatine, MD, MPH
James A. Underberg, MD
SESSION II: HYPERTENSION AND CARDIO-RENAL SYNDROME
8:00am - 8:10am Opening Remarks
George L. Bakris, MD
8:10am - 8:40am Low Diastolic BP and Progression to CKD
Aldo J. Peixoto, MD
8:40am - 9:10am Device Therapy & Resistant Hypertension
George L. Bakris, MD
9:10am - 9:40am New Methodologies for the Management of Hyperkalemia in Kidney Disease
Matthew R. Weir, MD
9:40am - 10:10am The Contribution of Aldosterone in Obesity-Related Hypertension
Colleen M. Majewski, MD
10:10am - 11:15am Morning Break/Exhibit Hall
 
11:15am - 12:15pm Clinical Controversies in Hypertension Management
moderator:
George L. Bakris, MD
presenters & discussants:
Colleen M. Majewski, MD
Aldo J. Peixoto, MD
Matthew R. Weir, MD
12:30pm - 2:00pm CME Lunch Symposium A
Triglyceride and Mixed Dyslipidemia Management:
The Changing Landscape of CV Risk Reduction
Supported by an educational grant from AstraZeneca
Christie M. Ballantyne, MD (Chair)
Terry A. Jacobson, MD
Michael Miller, MD
Dariush Mozaffarian, MD, DrPH
12:30pm - 2:00pm CME Lunch Symposium B
New Frontiers in Obesity Management:
Advances in Neurobiological Treatment Strategies
Supported by an educational grant from
Takeda Pharmaceuticals International, Inc., US Region and
Orexigen
Caroline M. Apovian, MD (Chair)
Louis J. Aronne, MD
Lee M. Kaplan, MD, PhD
Joshua Thaler, MD, PhD
12:30pm - 2:00pm CME Lunch Symposium C
Individualizing Therapy in Patients with Stable Ischemic Heart Disease: Managing the Full Spectrum of Comorbidities and Cardiometabolic Risk Factors
Supported by an educational grant from Gilead Sciences, Inc.
JoAnne M. Foody, MD (Chair)
Suzanne V. Arnold, MD
Deepak L. Bhatt, MD, MPH
Peter H. Stone, MD
SESSION III: DIABETES MANAGEMENT
2:00pm - 2:30pm Is Alzheimer's Disease Type 3 Diabetes?
C. Ronald Kahn, MD
2:30pm - 3:00pm Type 2 Diabetes Management 2014
John B. Buse, MD, PhD
3:00pm - 3:30pm Initiating and Monitoring Insulin Therapy
Howard A. Wolpert, MD
3:30pm - 4:15pm Afternoon Break/Exhibit Hall
 
4:15pm - 4:45pm The Bionic Pancreas
Edward R. Damiano, PhD
4:45pm - 5:45pm Diabetes Panel Session moderator:
Jay S. Skyler, MD
presenters & discussants:
John B. Buse, MD, PhD
Edward R. Damiano, PhD
C. Ronald Kahn, MD
Howard A. Wolpert, MD
5:45pm Closing Remarks
Jay S. Skyler, MD
PROFESSIONAL EDUCATION (non-CME)
6:00pm - 7:00pm Symposium A (non-CME)
Take a Closer Look at Homozygous Familial Hypercholesterolemia
Sponsored by Aegerion Pharmaceuticals
Daniel Wise, MD
6:00pm - 7:00pm Symposium B (non-CME)
Treatment Considerations for Generalized Lipodystrophy
Sponsored by AstraZeneca
Jean Chan, MD
7:00pm - 9:00pm CME Dinner Symposium A
Improving Awareness and Outcomes in Lipodystrophy Syndromes:
Clinical Manifestations, Diagnosis, and Evolving Therapeutic Strategies
Supported by an educational grant from AstraZeneca | Endorsed by Lipodystrophy United
Abhimanyu Garg, MD (Chair)
Rebecca J. Brown, MD
Elif A. Oral, MD
Andra Stratton
7:00pm - 9:00pm CME Dinner Symposium B
Integrated Management of the Complexities of Cardiometabolic Diseases: A Patient-Centric Team Approach
Supported by an educational grant from Merck & Co., Inc.
Lawrence Blonde, MD (Chair)
Honey E. East, MD
Martha M. Funnell, MS, RN, CDE
Daniel M. Riche, PharmD

Saturday, October 25, 2014

6:15am - 7:45am CME Breakfast Symposium
Overcoming Obstacles in Obesity Management:
New Tools, Techniques, and Treatment Strategies
Supported by an educational grant from Eisai, Inc.
Louis J. Aronne, MD (Chair)
Caroline M. Apovian, MD
Harold E. Bays, MD
Thomas A. Wadden, PhD
SESSION IV: LIFESTYLE AND OBESITY MANAGEMENT
8:00am - 8:10am Opening Remarks
Robert H. Eckel, MD
8:10am - 8:50am Impact of Gut Microbiota on Obesity and CVD Risk
Peter J. Turnbaugh, PhD
8:50am - 9:30am Long-Term Effects of Metabolic Surgery
Lee M. Kaplan, MD, PhD
Francesco Rubino, MD
9:30am - 10:00am Sleep Apnea and Restricted Sleep Patterns:
Impact on Cardiometabolic Health
Virend K. Somers, MD, PhD
10:00am - 10:15am Morning Break
 
10:15am - 11:00am Long-Term Use of Obesity Medications:
How to Sustain Weight Loss
Caroline M. Apovian, MD
11:00am - 11:30am Behavioral Strategies in Obesity Management Thomas A. Wadden, PhD
11:30am - 11:50am Role of Exercise in the Modulation of Nontraditional CHD Risk Factors William E. Kraus, MD
11:50am - 12:30pm Obesity Panel Discussion
moderator:
Robert H. Eckel, MD
discussants:
Caroline M. Apovian, MD
Lee M. Kaplan, MD, PhD
William E. Kraus, MD
Francesco Rubino, MD
Virend K. Somers, MD, PhD
Peter J. Turnbaugh, PhD
Thomas A. Wadden, PhD
12:30pm Closing Remarks Robert H. Eckel, MD

Top of Page